Latest Beverages News

Page 3 of 17
RooLife Group (ASX: RLG) reported a 268% jump in FY2026 revenue to nearly $10 million, driven by rapid growth in its own food and beverage products, including RLG Coffee in China. Despite this, the company recorded a $3.58 million net loss, weighed down by impairment charges and R&D investments in renewable energy.
Victor Sage
Victor Sage
28 Aug 2026
SPC Global reported a 27% rise in normalised EBITDA for FY26 to $38.5 million, supported by a $100 million equity raise that halved net leverage. The company’s strategic pivot to higher-margin branded products and operational efficiencies set the stage for targeted double-digit revenue and EBITDA growth in FY27.
Victor Sage
Victor Sage
28 Aug 2026
Coast Entertainment (ASX:CEH) posted a $6.1 million net profit in FY26, driven by strong theme park attendance and record revenues, while securing a major land development approval that boosts asset value by over $50 million.
Victor Sage
Victor Sage
21 Aug 2026
Bega Cheese Limited has delivered a robust FY2026 with a $54.8 million statutory profit, a 6.7% revenue increase, and a raised final dividend of 7.5 cents per share. The company is advancing its strategic growth plans focused on high-protein products, international expansion, and sustainability initiatives.
Victor Sage
Victor Sage
20 Aug 2026
Auckland Airport posted a 3% revenue increase and a stable underlying profit of NZD 309 million in FY26, driven by robust passenger growth and a $1 billion infrastructure push, while cautioning on near-term fuel price volatility and geopolitical risks.
Victor Sage
Victor Sage
20 Aug 2026
Orora’s FY26 results reveal a $616.6 million statutory loss driven by a $742.8 million Glass impairment, offset by robust growth in its Cans business and disciplined capital management.
Victor Sage
Victor Sage
13 Aug 2026
De.mem Limited is poised for a record 2026, driven by 29 consecutive quarters of cash receipts growth, positive operating cashflow, and strategic expansion into the gold mining sector through Core Chemicals.
Maxwell Dee
Maxwell Dee
7 Aug 2026
Argent BioPharma's licensing partner Splash Beverage Group has launched the US veterinary development program for CannEpil®, targeting companion-animal oncology and chronic pain. Led by industry veteran Dr Hunter Land, the initiative follows a defined FDA regulatory pathway and could broaden CannEpil®’s commercial footprint beyond human neurology.
Victor Sage
Victor Sage
6 Aug 2026
AoFrio’s revenue fell 21.5% in 1H26, dragged down by a 50.5% plunge in motor sales due to US tariffs, while IoT revenue grew modestly. The company launched new cellular and software platforms, raised NZD 8.9 million, and is expanding into Food Retail, but full-year revenue growth now looks unlikely.
Sophie Babbage
Sophie Babbage
5 Aug 2026
Peak Processing (ASX: PKP) has recorded its first positive Group EBITDA quarter, driven by record beverage production and a significant US manufacturing agreement, marking a pivotal turnaround in FY26.
Victor Sage
Victor Sage
29 July 2026
De.mem Limited posted its second highest quarterly cash receipts of approximately $9.6 million for June 2026, marking 29 consecutive quarters of growth and positive operating cash flow of $424k. The company’s strong half-year performance is underpinned by recurring revenues, a robust Western Australian business, and record results from its German subsidiary.
Victor Sage
Victor Sage
29 July 2026
Argent BioPharma has eliminated US$5.5 million in secured debt through a global licensing agreement for its CannEpil® epilepsy therapy, while completing a key acquisition and advancing clinical trials in veterinary therapeutics.
Ada Torres
Ada Torres
28 July 2026

Browse the archive

Full archive